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Abstract
The cornea is a complex structure with complex functions aiming to protect 
the internal ocular tissues and transmit and refract the coming light rays. Corneal 
dystrophies are a group of relatively infrequent genetic corneal disorders in which 
an abnormal material accumulates in the cornea causing variable loss of its clarity. 
On the other hand, corneal degenerations are more common and usually result from 
physiologic changes related to aging, particular disease, or long-standing environ-
mental insults to the cornea. Ectatic corneal disorders are usually characterized by 
bilateral loss of corneal biomechanical strength leading to progressive thinning and 
bulging of the cornea with resultant astigmatism and decreased visual acuity. In 
this chapter, we will describe the basic embryological, anatomical, histologic, and 
physiological features of the cornea. Then, we will go over the clinical, histopatho-
logic, medical, and surgical aspects of dystrophic, degenerative, and ectatic corneal 
disorders.
Keywords: cornea, physiology, embryology, anatomy, histopathology, genetic, 
classification, epidemiology, clinical, topography, dystrophy, degeneration, ectasia, 
keratoconus, keratopathy, keratoplasty
1. Introduction
The wall of the eye globe is composed of the cornea and the sclera. The latter 
covers the posterior four-fifths of the globe with anterior and posterior openings 
for the cornea and the optic nerve, respectively. The cornea is the most anterior part 
of the globe and is normally optically clear. A healthy overlying tear film is impor-
tant for the optimal function of the cornea and the esthetic wellness of the ocular 
surface.
The cornea is a complex structure that is responsible for protection and about 
three-quarters of the optical power of the natural eye with the remainder coming 
from the crystalline lens. The normal cornea is devoid of blood vessels to insure 
optimal transmission of light rays. Oxygen and nutrients are supplied, and meta-
bolic products are eliminated primarily through the tear film anteriorly and aqueous 
humor posteriorly. The cornea is one of the most densely innervated tissues in the 
body. Thus, traumatic corneal abrasions, bacterial keratitis, and bullous keratopa-
thy are associated with severe pain, tearing, and photophobia. The corneal nerve 
plexuses are supplied by the first division (ophthalmic nerve) of the fifth cranial 
nerve (trigeminal nerve) [1].
Corneal dystrophies are defined as a group of slowly progressive, usually inher-
ited, bilateral, and symmetric corneal opacifying disorders that might be associated 
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with variable degrees of decreased vision and discomfort. Typically, they are not 
linked to environmental or systemic factors. Nevertheless, there are exceptions 
to each portion of the corneal dystrophies’ definition, as some dystrophies are 
unilateral and asymmetric and have no recognizable heredity and have associated 
systemic findings [2]. Based on the cellular origin of corneal dystrophy, a modi-
fied anatomic classification is proposed consisting of epithelial and subepithelial, 
epithelial-stromal, stromal, and endothelial dystrophies [3].
Degenerations generally result from steady deterioration of the tissues that was 
previously normal with subsequent loss of their functional activity. Corneal degen-
erations are characterized by the deposition of a specific material, stromal thinning, 
and vascularization. They are not hereditary and can be unilateral. The cornea may 
undergo changes associated with ultraviolet light stimulation and oxidative stress 
that are thought to be responsible for the progression of degenerative processes [4, 5].
Corneal ectasia refers to a group of noninflammatory conditions characterized 
by bilateral loss of corneal biomechanical strength leading to progressive thinning 
and bulging of the cornea with resultant irregular astigmatism and decreased visual 
acuity. Examples include keratoconus, post laser-assisted in situ keratomileusis 
(LASIK) ectasia, pellucid marginal degeneration, and keratoglobus [1].
We will start this chapter by describing the basic sciences of the normal human 
cornea including embryological, anatomical, histologic, and physiological features 
of the cornea with mentioning selected related functional aspects. Later, we will 
discuss the most important corneal dystrophies, degenerations, and ectasia from 
clinical, histopathologic, and management points of view.
2. The basic sciences of the cornea
2.1 Corneal embryology
Corneal development and differentiation are the last in the well-organized series 
of ocular tissue formation. Thus, normal corneal development depends on normal 
development of the lens and optic cup. The corneal epithelium is derived from 
the surface ectoderm, while the corneal stroma, including Bowman’s layer, and 
endothelium are derived from the neural crest cells. The Descemet’s membrane is 
synthesized by endothelial cells and acts as the basement membrane of the corneal 
endothelium [6, 7].
The corneal development begins on the 22nd day of gestation as the surface ecto-
derm, the primordium of the corneal epithelium, and can be identified at the start of 
the 6th week of intrauterine age [8]. The neural crest cells come in three distinct waves. 
The first wave, in the 7th week, migrates between the primitive corneal epithelium  
and the lens epithelium to form the corneal endothelium. The second wave migrates to 
the area situated between the future corneal endothelium and the corneal epithelium 
and gives rise to keratocytes, the cells of the corneal stroma. The third wave of neural 
crest cells is located in the primitive anterior chamber to form the iris stroma [9–12].
Keratan sulfate is a proteoglycan that is produced by keratocytes and can 
be demonstrated at the 8th week of gestation. It is present in keratocytes and 
endothelial cells but not the epithelial cells [13–15]. The early corneal epithelium 
is composed of two layers, apical and basal layers. The outer (apical) cells are 
cuboidal without microvilli and are joined together by junctional complexes: zonula 
occludens and zonula adherens. They are connected to the basal cell by desmosomes 
[16]. The epithelium increases to three cell layers at 10-day postpartum and contin-
ues to thicken until reaching the adult thickness of about six layers by the 4th week 
of life [17].
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2.2 Corneal anatomy, histology, and physiology
2.2.1 Corneoscleral limbus
The corneal limbus is simply described as the transition zone between the 
peripheral corneal margin and the anterior sclera. Its width is approximately 
1–1.5 mm. One of the important characteristics of the limbus is that it contains the 
corneal stem cells detected in the basal cell layer. The limbus can be defined from 
histological, pathological, and surgical points of view.
From histological aspects, the anterior margin of the limbus is bounded by a 
line connecting the peripheral termination of Bowman’s layer from the corneal 
epithelial side and the peripheral termination of Descemet’s membrane, known as 
Schwalbe line, from the endothelial side. The peripheral margin is bordered by the 
scleral spur. From pathologists’ point of view, a vertical line that is perpendicular to 
the scleral spur was added to define the peripheral margin [18]. Surgeons divide the 
limbus into two zones: a central blue zone and a peripheral concentric white zone. 
The area containing Bowman’ layer and Descemet’s membrane is seen as blue. The 
trabecular meshwork is located under the white zone [19].
2.2.2 Corneal anatomy
The cornea is the round transparent portion of the eyeball. It is the strongest 
refractive component of the optical system of the eye. To maintain its transparency, 
the normal cornea is avascular, relatively acellular, and relatively dehydrated with 
extraordinary organization of the stromal collagen lamellae. The diameter of the 
cornea measures 11–12 mm in horizontal meridian and 10–11 in vertical meridian. The 
average central thickness of the cornea is 520 and 650 μm peripherally. The corneal 
stroma is 78% water. This percentage is controlled by an intact epithelium and a nor-
mally functioning endothelial pump. The refractive index of the cornea is 1.376 [18].
In the following subsections, we will describe the histology and physiology of 
different layers of the cornea from the front to the back: epithelium, Bowman’s 
layer, stroma, Descemet’s membrane, and endothelium.
2.2.3 Corneal epithelium
As previously mentioned, the corneal epithelium is derived from the embryonic 
surface ectoderm and lies on the outer surface of the cornea. The epithelium is 
composed of 5–6 layers of nonkeratinized stratified squamous epithelium overlying 
a single layer of basal cells. It is 50 μm thick. Complete renewal of the epithelial cells 
occurs in 7–10 days. Three distinct layers of epithelial cells are identified: superficial 
flattened cells, middle wing cells, and deep basal cells [18].
The superficial and the wing cells differentiate from the basal cells. There are 
approximately 6000 basal cells/mm2 in a normal cornea. They are derived from the 
corneal limbal stem cells. The new cells migrate from the limbus in a centripetal 
fashion at a speed of approximately 120 μm/week. Gab junctions serve to provide 
communication channels between basal cells. A basal lamina that is 50 nm thick, 
and is composed of type IV collagen, is actively secreted by the basal cells. The 
cells are attached to the underlying basal lamina via hemidesmosomes. Recurrent 
epithelial erosions, seen in patients with epithelial basement membrane dystrophy 
(EBMD), are caused by alteration of hemidesmosomes [18].
On the top of basal cells are 2–3 cell layers of wing cells. They resemble wings in 
cross section. Wing cells are joined together by zonulae occludentes forming a semi-
permeable membrane preventing components of the tear film from gaining entry 
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to the corneal stroma. The superficial layer is composed of 2–3 rows of flattened 
cells. They shed in the tear film and are replenished by other cells. Microplicae and 
microvilli are observed on the apical surface of the superficial cells. Epithelial cells 
are attached to each other by desmosomes. Topical anesthetic abuse causes a decline 
in the number of desmosomes with resultant impaired healing [20].
2.2.4 Bowman’s layer
Bowman’s layer represents the most anterior part of the stroma and lies directly 
posterior to the basal lamina of the corneal epithelium. Bowman’s layer is not con-
sidered a true membrane and does not stain with periodic acid-Schiff (PAS). It is 
8–12 μm thick and composed of type I and type V collagen. After injury, Bowman’s 
layer does not regenerate and, thus, a scar will form. In contrast to the stroma, the 
collagen lamellae are smaller and randomly organized [18].
Bowman’s layer is critical in supporting the corneal biomechanics through its 
stiff and strong nature. Weakening of this layer can result in ectatic corneal disor-
ders, such as keratoconus, due to loss of the biomechanical support [21].
2.2.5 Corneal stroma
The corneal stroma is derived from the neural crest cells. It constitutes around 
90–95% of the corneal thickness. Numerically, the central corneal thickness 
measures about 0.52 mm and thickens to 0.65 mm in the periphery. It has cor-
neal stromal collagen lamellae, 200–250 lamellae that are arranged parallel to 
the surface of the cornea. They are predominantly made from type I and type V 
collagens. Keratan sulfate and dermatan sulfate are the primary proteoglycans of 
the stroma. These proteoglycans are located between the lamellae maintaining a 
constant interlamellar distance, an important factor in eliminating light scatter 
and, thus, a clear cornea [18]. In 2013, an acellular layer measuring approximately 
10 μm in the posterior stroma, named the pre-Descemet’s layer (or Dua’s layer), 
was introduced [22].
There are approximately 2.4 million keratocytes in the corneal stroma scattered 
in between the lamellae. They synthesize collagen and proteoglycans. Keratocytes 
are abundant in mitochondria, rough endoplasmic reticulum, and Golgi appa-
ratuses. The plasma membranes are fenestrated, and they communicate via gab 
junctions. There is a documented decline in the cell density associated with age [18].
The anterior part of the stroma is typically drier than the posterior part. This 
is caused by the drying effect of the atmosphere anteriorly and the wetting effect 
of the aqueous humor posteriorly. An enlarged spacing between the lamellae, as in 
cases of corneal stromal edema from endothelial injury, will result in hazy cornea 
and decreased visual acuity [18].
2.2.6 Descemet’s membrane (DM)
Descemet’s membrane is a true basement membrane, for corneal endothelium, 
that is PAS positive. The thickness of DM varies according to the age of the indi-
vidual. It is continuously secreted by the endothelium through life. In newborns, it 
measures about 2–4 μm in thickness and reaches to 10–12 μm in adults [18].
Histologically, DM has two layers: an anterior banded layer produced during 
fetal life and a posterior non-banded layer produced after birth. It is made of type 
IV collagen, laminin, and fibronectin [18].
DM provides support and adhesion to endothelial cells. Under patho-
logic conditions, it works as a biologic barrier to the phagocytic, toxic, and 
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enzymatic degradation. Notably, DM is weakly attached to the overlying 
stroma, or pre-Descemet’s layer, and can be surgically dissected as one piece 
(Descemetorrhexis) [18].
2.2.7 Corneal endothelium
The corneal endothelium is the innermost layer of the cornea. It is about 4–6 μm 
thick. As mentioned earlier, the endothelium originates from neural crest cells. 
The cells cannot be replenished if lost. There are about 500,000 endothelial cells 
covering the posterior surface of the cornea with a density of 3000 cells/mm2. There 
is approximately 0.6% endothelial cell loss per year, and this rate increases signifi-
cantly after traumatic, iatrogenic, inflammatory, or infectious conditions affecting 
the endothelium. The most common normal cell shape is hexagonal with minimal 
polymegathism and pleomorphism [18].
To maintain the corneal clarity, the endothelium works as a barrier and as a 
metabolic pump. Endothelial cells are linked together by interdigitations and focal 
tight junctions. They communicate via gab junctions. Some nutrients are allowed 
to pass paracellularly to the remaining corneal layers indicating a semipermeable 
nature of the endothelial cell layer [18].
The corneal endothelium is a highly active tissue. This is evident by the presence 
of numerous mitochondria, the prominent endoplasmic reticulum, ribosomes, and 
Golgi apparatus. The fluid is pumped out of the corneal stroma into the anterior 
chamber via pinocytic vesicles [18].
Hassall-Henle bodies, or peripheral cornea guttae, are considered a natural 
aging process in which small excrescences are observed in the peripheral part of 
Descemet’s membrane. They denote focal areas of thickening of Descemet’s mem-
brane. On the other hand, central cornea guttae are pathologic in nature and are 
associated with progressive corneal stromal and epithelial edema as in patients with 
Fuchs’ endothelial dystrophy [18].
3. Corneal dystrophies
Generally, corneal dystrophies are defined as a group of progressive, inherited, 
mostly bilateral, and symmetric, variable corneal opacifying disorders, which are 
usually not related to environmental or systemic conditions. The can be associated 
with blurred vision and ocular discomfort. Their onset is usually early in life but 
they manifest later clinically. They are slowly progressive and become more promi-
nent with age. There are exceptions to the corneal dystrophies definition: some 
dystrophies are unilateral or bilateral asymmetric, some have no obvious heredity, 
and some have related systemic abnormalities [1, 2].
In 2015, the International Committee on the Classification of Corneal 
Dystrophies (IC3D) proposed a modified anatomic classification on the basis of the 
cellular origin of the corneal dystrophies consisting of [3]:
1. Epithelial and subepithelial dystrophies
2. Epithelial-stromal transforming growth factor β-induced gene (TGFBI) 
dystrophies
3. Stromal dystrophies
4. Endothelial dystrophies
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An evidence-based category system was suggested to indicate the level of evi-
dence that supports the existence of a given corneal dystrophy. In this system, each 
dystrophy is organized according to the clinical phenotype, with a template summa-
rizing genetic, clinical, and pathologic information. The system is upgradable and 
can be retrieved at www.corneasociety.org. The categories are as follows [23]:
Category 1 (C1): a well-defined corneal dystrophy in which the gene has been 
mapped and identified and the specific mutations are known.
Category 2 (C2): a well-defined corneal dystrophy that has been mapped to one 
or more specific chromosomal loci, but the gene(s) remains to be identified.
Category 3 (C3): a well-defined corneal dystrophy in which the disorder has not 
yet been mapped to a chromosomal locus.
Category 4 (C4): this category is reserved for a suspected, new, or previously 
documented corneal dystrophy, although the evidence for it, being a distinct entity, 
is not yet convincing.
In the following subsections, we will describe the clinical, genetic, and histo-
pathologic characteristics of the common corneal dystrophies from anterior to 
posterior: epithelial and subepithelial, epithelial-stromal (TGFBI), stromal, and 
endothelial dystrophies.
3.1 Epithelial and subepithelial corneal dystrophies
The included dystrophies are:
1. Epithelial basement membrane dystrophy (EBMD)
2. Epithelial recurrent erosion dystrophies (EREDs)—Franceschetti corneal 
dystrophy (FRCD), Dystrophia smolandiensis (DS), and Dystrophia 
helsinglandica
3. Subepithelial mucinous corneal dystrophy (SMCD)
4. Meesmann corneal dystrophy (MECD)
5. Lisch epithelial corneal dystrophy (LECD)
6. Gelatinous drop-like corneal dystrophy (GDLD)
3.1.1 Epithelial basement membrane dystrophy (EBMD)
EBMD, also known as map-dot-fingerprint dystrophy [24], Cogan’s microcystic 
epithelial dystrophy [25], and anterior basement membrane dystrophy, is the most 
common anterior corneal dystrophy. It can reach up to 70% in individuals above the 
age of 50 years and is found to be infrequent in the pediatric population [26]. It was 
found to be more common in females [27].
Inheritance: mostly sporadic with familial cases have been reported. Thus, they 
are thought to be degenerative or caused by previous trauma.
Genetic locus and gene: 5q31. One report has identified TGFBI in two families.
Category: most cases are sporadic. C1 in rare cases.
Onset: usually in the second decade.
Symptoms: it maybe asymptomatic or associated with recurrent epithelial ero-
sions in 10% of patients due to poor adhesion of basal epithelial cells to the basal 
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laminar material. Irregular astigmatism might cause decreased vision and monocu-
lar diplopia. The severity of pathology can fluctuate with time.
Signs: can be isolated or combined and unilateral or bilateral.
• Maps: central or paracentral thickened, scalloped, circumscribed borders resem-
bling coastlines, associated with faint haze.
• Fingerprints: paracentral, hair-like, curvilinear concentric lines, best visual-
ized with retro-illumination.
• Dots: central, round or oval, non-staining, intraepithelial opacities. These lesions 
contain debris of degenerated epithelial cells.
• Bleb pattern: subepithelial bleb or cobble stone-like pattern, best seen by 
retro-illumination.
Histopathology:
• Maps: thickened intraepithelial, multilamellar, basement membrane.
• Fingerprints: intraepithelial extensions of basement membrane that are rib-like.
• Dots: intraepithelial cyst-like lesions containing degenerated cytoplasmic debris.
• Bleb pattern: subepithelial fibrillo-granular material accumulation.
• Bowman’s layer is not affected.
Management: in asymptomatic cases no intervention is required. When symp-
toms occur, the frequent use of lubricants is recommended (preferably preserva-
tive-free lubricants). Hypertonic drops (i.e., sodium chloride 3–5%) during the 
daytime and an ointment at night can be helpful. Topical antibiotics are needed in 
cases where there are erosions. Cautious wear of a bandage contact lens may help 
in providing comfort and healing. In severe cases, debridement of the epithelial 
surface might be needed, and, in some cases, a phototherapeutic keratectomy 
(PTK) might be helpful.
3.1.2 Epithelial recurrent erosion dystrophies (EREDs)
Inheritance: autosomal dominant.
Variants:
• Franceschetti corneal dystrophy (FRCD)
• Dystrophia smolandiensis (DS)
• Dystrophia helsinglandica (DH)
Genetic locus and gene: unknown.
Category: C3.
Onset: childhood.
Symptoms: recurrent epithelial erosion attacks that start in childhood and con-
tinue in adulthood. The attacks are usually nocturnal. Corneal opacification, which 
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may be visually significant if located centrally, occurs in about half of the cases. 
Painful erosive episodes usually decrease with age.
Signs: repeated epithelial erosions lasting up to 7 days in duration. Typically, no 
signs can be detected after healing of the attack. However, central subepithelial 
opacities, subepithelial fibrosis, or corneal keloids may develop later in life.
Histopathology: the basal epithelial cells are irregular with distended intercellular 
spaces. Intracellular and intercellular Alcian blue-positive deposits are present. 
Bowman’s layer is partial or completely destructed. Avascular pannus is between the 
basal epithelium and the Bowman layer [3].
Management: in asymptomatic patients, treatment is not required. Recurrent 
erosive episodes are treated as for recurrent epithelial erosions. Epithelial debride-
ment may be necessary in patient with irregular astigmatism.
3.1.3 Subepithelial mucinous corneal dystrophy (SMCD)
Inheritance: mostly autosomal dominant.
Genetic locus and gene: unknown.
Category: C4.
Onset: early childhood.
Symptoms: painful epithelial erosions that might decrease in frequency with age. 
The vision tends to deteriorate with time.
Signs: subepithelial haze denser in the center.
Histopathology: subepithelial band of eosinophilic, periodic acid-Schiff (PAS)-
positive, Alcian blue-positive, hyaluronidase-sensitive material is present anterior 
to the Bowman layer [3].
Management: recurrent erosive episodes are treated as for recurrent epithelial 
erosions.
3.1.4 Meesmann corneal dystrophy (MECD)
MECD is also known as Meesmann-Wilke syndrome and Meesmann’s juvenile 
epithelial corneal dystrophy [28, 29].
Inheritance: mostly autosomal dominant.
Variant: stocker-Holt variant.
Genetic locus and gene: 2 loci and 2 genes.
• Locus 12q13 (KRT3 gene)
• Locus 17q12 (KRT12 gene) in Stocker-Holt variant
Category: C1.
Onset: usually in the first decade.
Symptoms: most patients are asymptomatic. Glare, photophobia, decreased 
vision, or recurrent epithelial erosions may occur. It is slowly progressive or even 
nonprogressive. Patients affected with Stocker-Holt variant show more severe signs 
and symptoms with earlier onset.
Signs: bilateral and symmetric numerous central and peripheral intraepithelial 
vesicles most dense in the interpalpebral area. Gray opacities usually having a 
distinct border with some areas being spared. Microcysts are seen in about 80% of 
corneas and are more evident with retro-illumination. These cysts coalesce resulting 
in refractile linear opacities. Mild corneal thinning or reduced sensation may occur. 
In patients with Stocker-Holt variant, diffuse grayish punctate superficial opacities 
that stain with fluorescein are observed.
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Histopathology: the epithelium is thickened and disorganized exhibiting 
intraepithelial cysts filled with PAS-positive cellular debris. There is a multilaminar, 
thickened basement membrane extending into the basal epithelium. Bowman’s 
layer and corneal stroma that remain are not affected [3].
Management: in symptomatic cases, strategies for relief of the epithelial ero-
sions include topical antibiotics to protect against infection, heavy lubrication, and 
contact lens application. In more severe cases, epithelial debridement and corneal 
keratoplasty are considered [30].
3.1.5 Lisch epithelial corneal dystrophy (LECD)
History: Lisch epithelial corneal dystrophy (LECD) was first described in 1992 in 
five family members and three unrelated individuals who presented with unilateral 
or bilateral bands of grayish granular opacifications on the cornea [31].
Inheritance: X-chromosomal dominant.
Genetic locus and gene: Xp22.3, the gene is unknown.
Category: C2.
Onset: childhood.
Symptoms: asymptomatic if the dystrophy is not involving the pupillary axis. 
Slowly progressive with decreased visual acuity if the corneal center is involved.
Signs: gray opacities that come in different patterns including band-shaped, 
radial, feathery, and whorl-like. Multiple clear cysts are seen with indirect illumina-
tion resembling MECD. However, the difference is in the molecular genetics.
Histopathology: PAS-positive vacuolated cells are present in the epithelial surface [3].
Management: treatment only if the individual is symptomatic with heavy lubri-
cation. In some cases, debridement might be helpful. Phototherapeutic keratectomy 
(PTK) can be beneficial in some cases [32].
3.1.6 Gelatinous drop-like corneal dystrophy (GDLD)
GDLD was first described by Nakaizumi (1914) [33]. It was found to be more 
common in Japan.
Inheritance: autosomal recessive.
Genetic locus and gene: 1p32, tumor-associated calcium signal transducer 2 
(TACSTD2).
Category: C1.
Onset: during the first 2 decades.
Symptoms: blurred vision, photophobia, foreign body sensation, and tearing.
Signs: subepithelial lesions may look like band keratopathy initially. Mulberry 
configuration of nodules that stain with fluorescein can occur. This configuration 
indicates epithelial hyperpermeability. Vascularization and stromal scarring are 
seen later in the course of the disease.
Histopathology: amyloid deposits in the subepithelial and stromal [3].
Management: treatment for symptomatic cases includes heavy lubrication. 
Superficial keratectomy or keratoplasty can be helpful when there is visual impair-
ment. Recurrence is common following superficial keratectomy, lamellar kerato-
plasty, and penetrating keratoplasty [34].
3.2 Epithelial-stromal TGFBI dystrophies
The included dystrophies are:
1. Reis-Bücklers corneal dystrophy (RBCD)
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2. Thiel-Behnke corneal dystrophy (TBCD)
3. Lattice corneal dystrophy, type 1 (LCD1)
4. Granular corneal dystrophy, type 1 (GCD1)
5. Granular corneal dystrophy, type 2 (GCD2)
3.2.1 Reis-Bucklers corneal dystrophy (RBCD)
RBCD was first described in 1917. It is also known as geographic corneal dys-
trophy of Weidle, superficial granular corneal dystrophy, atypical granular corneal 
dystrophy, granular corneal dystrophy type 3, and anterior limiting membrane 
dystrophy type 1 [35].
Inheritance: autosomal dominant.
Genetic locus and gene: 5q31, transforming growth factor β-induced gene (TGFBI).
Category: C1.
Onset: during the first decade of life.
Symptoms: blurred vision and recurrent corneal epithelial erosions. It is slowly 
progressive. The frequency of recurrent corneal erosions tends to decline with age. 
It has a more aggressive course than Thiel-Behnke corneal dystrophy (TBCD). In 
addition, the diagnosis can be confused between RBCD and TBCD.
Signs: early in the course of the disease, there are varying densities of bilateral 
irregular geographic-like opacities with clear interruptions at the level of Bowman’s 
layer and anterior stroma. They are discrete in early stages and become diffuse with 
deeper involvement. As the disease progresses, these fine reticular lesions coalesce 
to form a confluent gray whitish opacity that might affect vision as the surface 
becomes more irregular. At later stages, the corneal sensation is reduced, and ring-
shaped (sometimes crescent-shaped) opacifications cover the central cornea and 
can extend to the mid-periphery. The most peripheral cornea remains clear.
Histopathology: granular sheet-like deposits replace Bowman’s layer. These 
deposits stain red with Masson trichrome. The anterior, middle, and even poste-
rior stroma can be involved in advanced cases. Electron microscopy is required to 
distinguish RBCD from TBCD. In RBCD, rod-shaped subepithelial bodies are seen, 
while curly fibers are characteristic for TBCD [3].
Management: treatment of corneal erosions is similar to that of other dystro-
phies. Phototherapeutic keratectomy (PTK) can be beneficial in some cases. In 
advanced corneal involvement, keratoplasty might be helpful.
3.2.2 Thiel-Behnke corneal dystrophy (TBCD)
TBCD is also known as corneal dystrophy of Bowman’s layer type II, curly fibers 
corneal dystrophy, Waardenburg-Jonkers corneal dystrophy, and, most commonly, 
“honeycomb dystrophy.” It was first described in 1967 [36–38].
Inheritance: autosomal dominant.
Genetic locus and gene: 5q31, TGFBI.
Category: C1.
Onset: during the first decade of life.
Symptoms: visual deterioration occurs later, and recurrent corneal epithelial ero-
sions are less frequent than in RBCD. Slowly progressive corneal scarring is the main 
cause of decreased vision. The recurrence of corneal erosions decreases with time.
Signs: irregularly shaped scattered opacities and solitary flecks at the level of the 
Bowman’s layer are present in the initial stages. Then, central honeycomb opacities 
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are observed in the subepithelial area. As in patients with RBCD, corneal opacities 
can progress peripherally and to deeper stromal layers. Prominent corneal nerves 
can be seen. The corneal periphery remains clear even as the lesions progress. 
Corneal sensation might be affected. Reis-Buckler’s dystrophy and Thiel-Behnke 
can be clinically distinguished by the minimal loss of corneal sensation and honey-
comb opacity that occurs with Thiel-Behnke dystrophy [37, 39].
Histopathology: irregular thickening and thinning of the epithelial layer due to 
irregular underlying stroma with focal absence of the epithelial basement membrane. 
Wavy saw-toothed superficial fibro-cellular pannus replaces the Bowman’s layer [3].
Management: treatment is indicated only in symptomatic cases. The episodes of 
recurrent erosion are treated like the previous dystrophies. Hypertonic drops and 
ointment may be beneficial. In some cases, debridement of the corneal epithelium 
may be necessary. Phototherapeutic keratectomy (PTK) can also help with recur-
rent erosions or superficial opacifications [37, 39]. Keratoplasty is reserved for 
deeper lesions, but the dystrophy may recur in the donor graft.
3.2.3 Lattice corneal dystrophy, type 1 (LCD1) and variants
Inheritance: autosomal dominant.
Variants: LCD (III, IIIA, I/IIIA, IV). Lattice corneal dystrophy type 2 (LCD2) is a 
misnomer and should be termed familial amyloidosis, Finnish type, or gelsolin type 
as suggested by the IC3D. LCD2 is also known as Meretoja syndrome.
Genetic locus and gene: 5q31, TGFBI.
Category: C1.
Onset: during the first two decades of life.
Symptoms: visual deterioration, discomfort, and pain. Recurrent attacks of 
corneal erosions occur early in the course of LCD1. Patients with progressive visual 
impairment are seen within the fourth decade.
Signs: central superficial fleck-like opacities are seen initially. By using retro-illu-
mination technique, sparse peripheral lattice lines are visible initially in the super-
ficial stroma (Figure 1A). Centrally located, superficial branching refractile lines 
resembling tree branches and round/ovoid whitish dots are also detected in the first 
decade (Figure 1B). Central and paracentral diffuse subepithelial haze develops 
alongside the lattice lines. They typically spare the limbus, Descemet’s membrane, 
and endothelium. The average depth in the stroma is about 79 μm [40]. Reduction 
of visual acuity is caused by the progression of the stromal haze (Figure 1C). LCD1 
may be asymmetric or even unilateral. Central thicker lattice lines are seen in vari-
ant LCD type IIIA, while LCD type IV is characterized by deeper deposits without 
epithelial erosion.
Figure 1. 
(A) The appearance of the lattice deposits with retro-illumination, (B) slit lamp appearance of the 
lattice configuration of the stromal deposits in this type of dystrophy, and (C) clinical appearance 
of an advanced case of lattice dystrophy.
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Figure 3. 
The same amyloid deposits staining with Congo red stain (original magnification 400× Congo red).
Histopathology: the corneal epithelium is atrophic with degenerative changes 
of basal epithelial cells. The Bowman’s layer is disrupted or even absent. 
Subepithelial accumulation and stromal accumulation of amyloid deposits alter 
the architecture of corneal collagen lamellae (Figure 2). These deposits stain 
positive with Congo red and show birefringence with polarizing light (Figure 3) 
[41]. Metachromasia and fluorescence are demonstrated with crystal violet and 
thioflavin T staining, respectively. Descemet’s membrane and the endothelium 
are normal [3].
Management: treatment is based on the symptoms and the depth of the deposits. 
Options might include phototherapeutic keratectomy (PTK) with anterior lesions 
and where there are recurrent corneal erosions, lamellar keratoplasty (LKP) and 
penetrating keratoplasty (PKP) for deeper lesions. Reports on recurrence after 
DLKP that was associated with incomplete removal of corneal stroma [42]. Overall, 
recurrence was reported to be earlier compared to macular and granular corneal 
dystrophies [43].
3.2.4 Granular corneal dystrophy, type 1 (classic) (GCD1)
Inheritance: autosomal dominant.
Genetic locus and gene: 5q31, TGFBI.
Category: C1.
Onset: early childhood.
Figure 2. 
The amyloid deposits within the stroma in lattice dystrophy (original magnification 200× hematoxylin & eosin).
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Symptoms: patients usually complain of glare, photophobia, and recurrent ero-
sions. Visual deterioration occurs as corneal opacification progresses with time as 
the opacities become more confluent.
Signs: initially, subepithelial verticillate-like opacities are evident by retro- and 
direct illumination. Later, there will be white well-defined granules with clear inter-
vening stroma (Figure 4). Typically, opacities do not extend to the limbus. With 
age, granules extend deeper into the corneal stroma close to Descemet’s membrane.
Histopathology: multiple stromal deposits may extend from deep epithelium to 
Descemet’s membrane. Hyaline opacities stain with Masson trichrome (Figure 5A 
and B) [3, 41].
Management: treatment options if symptomatic include lubrication, hypertonic 
solution, and bandage contact lenses. Phototherapeutic keratectomy (PTK) and 
keratoplasty for deeper lesions. Recurrence occurred in all grafts within 4 years [44].
3.2.5 Granular corneal dystrophy, type 2 (GCD2)
Nomenclature: also called combined granular-lattice corneal dystrophy or 
Avellino corneal dystrophy. It was named after the Avellino region in Italy, where 
first cases have been reported.
Inheritance: autosomal dominant.
Genetic locus and gene: 5q31, TGFBI.
Category: C1.
Onset: in homozygous patients, the onset is in early childhood. Heterozygous 
patients present in late childhood.
Figure 4. 
The clinical appearance of granular dystrophy (courtesy of Dr. Hatem Kalantan, associate professor, Department 
of Ophthalmology, King Saud University, Riyadh, SA).
Figure 5. 
(A) The histopathological appearance of the hyaline deposits in granular dystrophy (original magnification 200× 
periodic acid-Schiff) and (B) the same deposits highlighted using special stain (original magnification 200× 
Masson Trichrome).
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Symptoms: recurrent erosive attacks. Visual deterioration occurs when visual axis 
is involved. Homozygotes are having a more rapid course.
Signs: initially, very small superficial stromal tiny whitish dots with small spokes 
that are usually arranged linearly like a string of pearls. With time, the center of 
the opacity fades resembling a ring. The anterior stromal deposits take the shape of 
spiky stars, icicles, or spider. The posterior corneal stroma may demonstrate linear 
or dot-like branching stromal opacities. The lines or dashes in GCD2 can be differ-
entiated from LCD in that in GCD2 the lines are whiter, compared to the refractile 
nature of lattice lines in LCD. In addition, in GCD2, typically, the lines do not 
cross, while lattice lines in LCD characteristically intersect resulting in the lattice 
configuration. Compared to GCD1, patients with GCD2 have fewer stromal opaci-
ties (Figure 6). Homozygote patients present earlier with frequent superficial small 
dots and larger, dense superficial opacities in stroma that become deeper with age.
Histopathology: the abnormal corneal deposits extend from the basal epithelium 
to the deep stroma. Hyaline and amyloid materials are deposited and stain with 
Masson trichrome and/or Congo red (Figure 7). More severe histopathological 
findings are seen in homozygotes [3].
Management: treatment is usually not required. Refractive surgery is 
contraindicated.
3.3 Stromal dystrophies
The included dystrophies are:
Figure 7. 
The histopathological appearance of the two kinds of deposits: superficial hyaline deposits (black arrow) 
and the amyloid deposits (labeled as #2 with red arrow) deeper in the stroma (original magnification 100× 
periodic acid-Schiff).
Figure 6. 
The clinical appearance of Avellino dystrophy with classic combined spiky opacities as well as the granular 
deposits (courtesy of Dr. Majed Alkharashi, FRCS C, assistant professor, Department of Ophthalmology, King 
Saud University, Riyadh, SA).
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1. Macular corneal dystrophy (MCD)
2. Schnyder corneal dystrophy (SCD)
3. Congenital stromal corneal dystrophy (CSCD)
4. Fleck corneal dystrophy (FCD)
5. Posterior amorphous corneal dystrophy (PACD)
6. Central cloudy dystrophy of François (CCDF)
7. Pre-Descemet corneal dystrophy (PDCD)
3.3.1 Macular corneal dystrophy (MCD)
Nomenclature: macular corneal dystrophy (MCD) is also known as Groenouw 
corneal dystrophy type II and Fehr spotted dystrophy [45, 46].
Inheritance: autosomal recessive.
Variants: Three variants that are clinically indistinguishable but on the basis of 
immunoreactivity of specific sulfated epitopes of antigenic keratan sulfates (AgKS) 
in the cornea and the serum:
1. MCD type I: no AgKS reactivity in the cornea and in the serum.
2. MCD type IA: keratocytes demonstrate AgKS reactivity, but not the extracel-
lular tissue. No AgKS in the serum.
3. MCD type II: all deposits react with AgKS. Serum has normal or low levels of 
AgKS.
Genetic locus and gene: 16q22, carbohydrate sulfotransferase 6 gene—CHST6.
Category: C1.
Onset: during the first decade of life.
Symptoms: slowly progressive visual deterioration which becomes severe during 
the second and third decades. Light sensitivity and recurrent epithelial erosions can 
rarely be seen. Corneal sensation is reduced.
Signs: early in the course of the disease, central superficial whitish fleck-like opaci-
ties develop. Compared to GCD, these opacities extend peripherally to the limbus and 
the deep stroma down to Descemet’s membrane. The intervening corneal stroma devel-
ops a progressive and diffuse haze (Figure 8). The epithelium is typically intact and, 
thus, corneal epithelial erosions are rare. The corneal thickness is reduced. Later in the 
course of the disease, corneal guttata and, rarely, endothelial decompensation occur.
Histopathology: glycosaminoglycans (GAGs) accumulate intracellularly and 
in the extracellular space and are better demonstrated with Alcian blue stain 
(Figure 9A and B). Breaks in the Bowman layer are observed. Stromal thinning 
and an overlying epithelial hyperplasia. Descemet’s membrane and endothelium 
are involved. Descemet’s membrane thickening and guttata are seen infrequently 
[3, 41]. Ultrastructural imaging and three-dimensional imaging of corneas with 
MCD demonstrate a clear organization of proteoglycans around the collagen 
fibrils. The collagen fibril diameter is significantly smaller than those of the 
normal cornea [47].
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Management: the treatment depends on the symptoms. Photophobia may be treated 
with lubrication and tinted contact lens. Superficial opacities can be treated with PTK 
and keratoplasty with deeper lesions. Recurrence may appear on the donor grafts [48].
3.3.2 Schnyder corneal dystrophy (SCD)
Inheritance: autosomal dominant.
Genetic locus and gene: 1p36, UbiA prenyltransferase domain containing 
1—UBIAD1.
Category: C1.
Onset: the diagnosis is usually made during the second or third decade although 
onset may be in childhood. In patients with the crystalline form, diagnosis may be 
further delayed.
Symptoms: slowly progressive visual loss and glare. Scotopic vision is better than 
photopic vision. Corneal sensation decreases with age. It may be associated with 
hyperlipoproteinemia (type IIa, III, or IV). Significant visual deterioration usually 
occurs during the sixth decade.
Signs: clinical findings largely depend on the age of the patient. In patients who 
are 23 years or younger, a central round ring-like opacity or central comma-shaped 
subepithelial crystals are seen. Arcus lipoides usually develops in patients between 
23 and 38 years of age. Diffuse stromal haze also develops after the age of 38. 
Almost 50% of patients demonstrate corneal crystals, which may be unilateral, and 
can occur late in the disease course.
Figure 8. 
The clinical appearance of macular dystrophy.
Figure 9. 
(A) The histopathological appearance of the deposits in a case of macular dystrophy involving the full stromal 
thickness and the endothelium with secondary guttata (original magnification 200× periodic acid-Schiff) 
and (B) the glycosaminoglycan deposits in this dystrophy are demonstrated using Alcian blue stain (original 
magnification 200×).
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Histopathology: intracellular and extracellular esterified and unesterified 
phospholipids and cholesterol are deposited in basal epithelial cells, Bowman’s 
layer, and stroma. Fresh tissue stains positive with Oil Red O or Sudan black. 
Moreover, secondary amyloid and GAG depositions in cases with SCD were 
published [3].
Management: treatment is by excimer keratectomy or corneal transplantation 
procedures.
3.3.3 Congenital stromal corneal dystrophy (CSCD)
Inheritance: autosomal dominant.
Genetic locus and gene: 12q21.33, decorin, DCN.
Category: C1.
Onset: at birth.
Symptoms: variable degree of visual deterioration and less commonly photophobia. 
It is slowly progressive or even stationary.
Signs: diffuse, bilateral corneal clouding with whitish pan-stromal opacities. 
The corneal epithelium is intact. The corneal stroma is thicker than in normal 
individuals.
Histopathology: irregular separation of the corneal stromal lamellae that might 
contain amorphous material [3].
Management: spectacles or contact lenses for refractive errors, penetrating 
keratoplasty.
3.3.4 Fleck corneal dystrophy (FCD)
Inheritance: autosomal dominant.
Genetic locus and gene: 2q34, phosphoinositide kinase, FYVE finger 
containing— PIKFYVE.
Category: C1.
Onset: at birth or during the first years of life.
Symptoms: FCD is typically asymptomatic or associated with photophobia. It is a 
stationary dystrophy.
Signs: small, discrete, translucent, dandruff-like opacities scattered at any level 
of the corneal stroma and may extend to the limbus. The epithelium, Bowman’s 
layer, Descemet’s membrane, and endothelium are usually normal. The involvement 
can be asymmetric or unilateral.
Histopathology: the keratocytes are swollen and vacuolated and contain GAGs 
and complex lipids [3].
Management: treatment is usually not required.
3.3.5 Posterior amorphous corneal dystrophy (PACD)
Inheritance: autosomal dominant.
Genetic locus and gene: 12q21.33, deletion of keratocan (KERA), lumican (LUM), 
decorin (DCN), and epiphycan (EPYC).
Category: C1.
Onset: it is usually in the first decade of life.
Symptoms: mild slowly progressive, or nonprogressive, reduction of visual 
acuity.
Signs: diffuse gray sheet-like stromal opacities most prominent posteriorly. 
Corneal thinning is noted. Characteristic corneal flattening to less than 41 diop-
ters with hyperopia. Descemet’s membrane may be indented by the opacities. 
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Endothelial abnormalities have been reported. Other ocular associations include 
prominent Schwalbe’s line, fine iris processes, pupillary remnants, iridocorneal 
adhesions, and iris hypoplasia. Notably, there is no associated glaucoma.
Histopathology: irregular posterior stromal lamellae. Positive staining with colloidal 
iron anterior to the Descemet’s membrane. Localized attenuation of endothelial cells [3].
Management: if visual impairment is significant, penetrating keratoplasty is 
indicated.
3.3.6 Central cloudy dystrophy of Francois
Inheritance: mostly unknown. Autosomal dominant inheritance has been 
reported.
Genetic locus and gene: none.
Category: C4.
Onset: it usually presents in the first decade of life.
Symptoms: typically, asymptomatic.
Signs: nonprogressive central cloudy or rounded stromal opacities that are 
surrounded by clear tissue. It is clinically indistinguishable from posterior crocodile 
shagreen, a corneal degeneration. It has been associated with pseudoxanthoma 
elasticum, pre-Descemet’s dystrophy, glaucoma, polymorphic amyloid degenera-
tion, and keratoglobus.
Histopathology: no description has been reported in familial cases. Positive stain-
ing for GAGs [3].
Management: if visual impairment is significant, penetrating keratoplasty is 
indicated.
3.3.7 Pre-Descemet corneal dystrophy (PDCD)
Inheritance: there is no clear pattern of inheritance. It can be isolated although it 
has been described in certain families up to four generations. Autosomal dominant 
in inheritance in 1 pedigree has been reported in the punctiform and polychromatic 
PDCD. Deep corneal stromal opacities are frequently seen in X-linked ichthyosis.
Genetic locus and gene: isolated PDCD—unknown genetic locus and gene. PDCD 
associated with X-linked ichthyosis—Xp22.31, steroid sulfatase (STS).
Category: C1 in PDCD associated with X-linked ichthyosis. C4 in isolated PDCD.
Onset: usually during the fourth. However, it has been reported in children as 
young as 3 years.
Symptoms: typically, asymptomatic. Punctiform and polychromatic PDCD are 
stationary. Other forms are progressive.
Signs: the specific signs depend on the PDCD subgroups. Notably, many of the 
subgroups may represent sporadic or age-related degenerative changes. Deep stro-
mal focal, fine opacities that may be central, annular, or diffuse. The changes are 
more uniform and polychromatic in an otherwise normal cornea in the punctiform 
and polychromatic subtypes.
Histopathology: enlarged keratocytes in the posterior corneal stroma containing 
vacuoles and intracytoplasmic inclusions of lipid-like material [3].
Management: usually not required.
3.4 Endothelial dystrophies
The included dystrophies are:
1. Fuchs endothelial corneal dystrophy (FECD)
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2. Posterior polymorphous corneal dystrophy (PPCD)
3. Congenital hereditary endothelial dystrophy (CHED)
4. X-linked endothelial corneal dystrophy (XECD)
3.4.1 Fuchs endothelial corneal dystrophy (FECD)
FECD was first described in 1910 [49]. It is a noninflammatory, slowly pro-
gressive degeneration of endothelial cells which leads to corneal decompensation 
edema.
Inheritance: the genetic basis of FECD is complex and heterogeneous. Most cases are 
without a known inheritance pattern. Some autosomal dominant cases were reported.
Genetic locus and gene:
1. Early-onset FECD: 1p34.3-p32 (FECD1), collagen type VIII, alpha-2, COL8A2.
2. Late-onset FECD: reported genetic loci include 13pter-q12.13 (FECD2), 18q21.2-
q21.3 (FECD3), 20p13-p12 (FECD4), 5q33.1-q35.2 (FECD5), 10p11.2 (FECD6), 
9p24.1-p22.1 (FECD7), and 15q25 (FECD8). The gene is not identified.
Category: C1 in early-onset FECD, C2 in patients with identified genetic loci, and 
C3 in patients without known inheritance.
Onset: the patients are usually in the fourth decade or older. Early-onset FECD 
starts in the first decade. There is a female predominance at a ratio of 2.5:1 to 3:1.
Symptoms: progressive intermittent reduction in vision worse in the morning 
from epithelial/stromal edema caused by overnight eye closure. Epithelial erosions 
resulting from ruptured epithelial bullae typically cause pain, photophobia, and 
tearing. Patients also complain of progressive visual deterioration.
Signs: the signs of FECD can be reflected in four stages:
Stage 1: central cornea guttata that spreads peripherally. Some never progress to 
later stages. Corneal guttae in late-onset FECD are larger than those seen in early-
onset FECD.
Stage 2: endothelial decompensation and stromal edema. Corneal endothelium 
has a beaten metal-like appearance with a thickened Descemet’s membrane.
Stage 3: intraepithelial and interepithelial edema with epithelial bullae (bullous 
keratopathy).
Stage 4: subepithelial fibrosis, scarring, and peripheral superficial vasculariza-
tion occurring in long-standing cases.
Histopathology: thickening and multilaminar Descemet’s membrane with hyaline 
excrescences and atrophic endothelial cells that are reduced in number (Figure 10). 
There is an increasing waviness of the stromal collagen lamellae [3].
Management: treatment in early stages can be done by conservative measure. 
Hypertonic sodium chloride drops or ointment can be helpful [50]. Bandage 
contact lenses may alleviate pain from ruptured epithelial bullae. In advance cases a 
Descemet stripping endothelial keratoplasty (DSEK) procedure might be required 
either combined with cataract extraction or alone. In cases where there is opacifica-
tion of the stroma, a full penetrating keratoplasty might be necessary [51].
3.4.2 Posterior polymorphous corneal dystrophy (PPCD)
Inheritance: autosomal dominant. Isolated nonhereditary unilateral cases have 
been reported.
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Genetic locus and gene: there are three known loci as follows:
PPCD 1: 20p11.2-q11.2, unknown gene
PPCD 2: 1p34.3-p32.3, collagen, type VIII, alpha-2 (COL8A2)
PPCD 3: 10p11.22, zinc finger E box–binding homeobox 1 (ZEB1)
Category: C2 in PPCD 1, C1 in PPCD 2 and PPCD 3.
Onset: during the first decade of life.
Symptoms: initially asymptomatic. Gradual visual loss occurs secondary to cor-
neal edema. Endothelial changes often are possibly slowly progressive over years. 
Those changes may eventually lead to corneal decompensation.
Signs: asymmetric geographic gray opacities, vesicular lesions that can be single 
or grouped, usually in the inferior paracentral cornea. Gray-white endothelial bands 
with white flaky material along the bands. Diffuse opacification of Descemet’s 
membrane and large vesicular endothelial opacities are seen in some cases. Guttata 
can be rarely seen. Corneal steepening has been reported, especially in PPCD 3, 
with corneal keratometry power of more than 48.0 diopters. Visually significant 
corneal edema, peripheral iridocorneal adhesions, and glaucoma are well-docu-
mented manifestations of PPCD.
Histopathology: focal fusiform or nodular excrescences formed by multiple layers 
of collagen on the posterior surface of Descemet’s membrane. In addition, redupli-
cation of the endothelial cell layer, blebs, or discontinuities is observed [3].
Management: treatment in the majority of patients is not indicated unless the 
patient is symptomatic; then treatment steps are similar to that of Fuchs endothelial 
corneal dystrophy.
3.4.3 Congenital hereditary endothelial dystrophy (CHED)
Inheritance: autosomal recessive.
Genetic locus and gene: 20p13, solute carrier family 4, sodium borate transporter, 
member 11—(SLC4A11) gene mutations.
Category: C1, C3 in cases without SLC4A11 mutations.
Onset: at birth.
Symptoms: nonprogressive congenital corneal clouding associated with blurred 
vision and nystagmus. Usually no tearing or photophobia.
Signs: bilateral variable limbus-to-limbus corneal clouding with occasional 
focal gray spots. Extensive corneal thickening (double or triple the normal corneal 
thickness). Rarely, secondary band keratopathy and elevated intraocular pressure. 
Significantly lower than normal endothelial cell count.
Figure 10. 
Descemet’s membrane appearance in a case of Fuchs’ endothelial dystrophy with typical excrescences (original 
magnification 400× periodic acid-Schiff).
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Histopathology: diffuse epithelial and pan-stromal edema associated with defects 
in the Bowman’s layer. Degenerative and atrophic endothelial cells and a thickened 
laminated Descemet’s membrane (Figure 11) [3]. Subepithelial amyloid deposition 
was found in 6.6% (Figure 12) [52].
Management: most CHED patients require corneal transplantation for visual 
rehabilitation. Better outcomes were seen with patients with delayed onset of the 
disease. Descemet stripping endothelial keratoplasty (DSEK) is an alternative to 
full-thickness keratoplasty for CHED with promising results [53–55].
3.4.4 X-linked endothelial corneal dystrophy (XECD)
Inheritance: X-chromosomal dominant.
Genetic locus and gene: Xq25, unknown gene.
Category: C2.
Onset: at birth.
Symptoms: asymptomatic and nonprogressive in females, minimally progressive 
decrease in vision in males.
Signs: in males, congenital corneal clouding that can range from diffuse haze to 
ground-glass and milky appearance of the cornea with possible nystagmus. It can 
present only with moon crater-like endothelial changes with or without secondary 
band keratopathy. In females, moon crater-like endothelial changes are observed.
Figure 11. 
The appearance of thick Descemet’s membrane with attenuated endothelium in CHED (original magnification 
400× periodic acid-Schiff).
Figure 12. 
Subepithelial amyloid deposits (black arrow head) in another case of CHED (original magnification 100× 
hematoxylin & eosin).
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Histopathology: irregularity and thinning of the epithelium and Bowman’s 
layer. Moon crater-like endothelial changes and subepithelial keratopathy. 
Irregularly arranged stromal collagen lamellae. Irregular thickening of 
Descemet’s membrane with atypically appearance or loss of endothelial 
cells [3].
Management: a penetrating keratoplasty may be indicated in males in which 
corneal opacification significantly impairs vision.
4. Corneal degenerations
Corneal degenerations represent physiological decomposition or alteration of 
tissue elements and/or functions. They usually occur later in life with variable rate 
of progression and can be asymmetrical.
4.1 Epithelial and subepithelial degenerations
4.1.1 Pterygium
It is similar to pinguecula histopathologically where the substantia propria shows 
pseudo-elastotic changes, numerous blood vessels, and curly fibers but invades the 
cornea resulting in loss of Bowman’s layer and epithelial changes (Figure 13A and B). 
They can cause astigmatism, interfere with contact lens fitting, and may cause ocular 
motility restriction. Advanced pterygia are treated surgically with the use of antime-
tabolites or conjunctival graft [56].
4.1.2 Environmental proteinaceous corneal degeneration (EPCD)
Previously known as “spheroidal degeneration” or “climatic droplet keratop-
athy.” It is characterized by the presence of yellowish aggregates that accumulate 
near the limbus and then progressively extend toward the central part of the 
cornea within the palpebral fissure. The globular amorphous material is primar-
ily deposited in the area of Bowman’s layer and can be demonstrated using an 
elastic stain (Figure 14). It can be primary or secondary, affecting males, and is 
related to cornea microtrauma caused by wind, dust, and ultraviolet radiation 
[57, 58].
Figure 13. 
(A) The clinical appearance of a nasal pterygium and (B) pterygium showing pseudo-elastotic degeneration 
with an area of limbal stroma and climatic droplet keratopathy (CDK) deposits (original magnification 200× 
hematoxylin & eosin).
23
Corneal Dystrophies and Degenerations
DOI: http://dx.doi.org/10.5772/intechopen.84426
4.2 Stromal (central)
Central stromal degenerations include:
1. Mosaic (crocodile) shagreen
2. Cornea farinata
3. Polymorphic amyloid degeneration
4.3 Peripheral stromal
Peripheral stromal degenerations include:
1. White limbal girdle of Vogt: types I and II
2. Corneal arcus
3. Senile furrow degeneration
4. Terrien’s marginal degeneration
4.4 Post-inflammatory corneal degenerations
4.4.1 Band-shaped keratopathy
Occurs as dense calcium deposits in the form of whitish calcium hydroxyapatite 
or yellowish hydroxyl apatite and phosphate within the superficial cornea and 
Bowman’s layer across the interpalpebral fissure (Figure 15). Common causes 
include hypercalcemia of variable etiology, chronic ocular diseases such as uveitis, 
and gout, and it can be idiopathic. It can be safely treated by calcium chelation 
using warm neutral disodium ethylenediaminetetraacetic acid (EDTA) [59].
4.4.2 Salzmann’s nodular degeneration
Initially described in 1925 as a nodular post-inflammatory keratopathy resulting 
in disruption of Bowman’s layer, subepithelial fibrosis and vascularization [60]. 
Figure 14. 
An early case of CDK with the deposits at Bowman’s layer level (original magnification 200× elastic stain).
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It appears to affect middle-aged women and to have good prognosis if properly 
treated medically using lubrication and surgically by superficial keratectomy [61].
The electron microscopy of these nodules shows irregular lamellae, and kera-
tocytes that are covered by an interrupted basement membrane Bowman’s layer is 
replaced by collagenous material, which shows positive vimentin straining [57].
4.4.3 Peripheral hypertrophic subepithelial corneal degeneration
It is a more recently recognized uncommon corneal degeneration, which is typi-
cally peri-limbal, slowly progressive, and bilateral. It tends to occur in white women 
with unknown etiology and, however, resembles Salzmann’s nodular degeneration 
in appearance (Figure 16A and B) [62, 63]. Ultraviolet radiation and limbal insuf-
ficiency have been proposed in the pathogenesis [64].
The fibrotic process has been linked to low-grade inflammation with low TGF 
F-B1 concentrations [62]. Surgical excision might be required for treatment of 
symptomatic cases, and the recurrence is not common [63].
4.4.4 Others
Amyloid degeneration and lipid keratopathy.
4.5 Endothelial
Hassall-Henle bodies.
Figure 15. 
The corresponding subepithelial calcium deposits (original magnification 400× hematoxylin & eosin).
Figure 16. 
(A) Clinical case of peripheral hypertrophic subepithelial corneal degeneration (PHSD) and (B) epithelial 
thickening, absence of Bowman’s layer and subepithelial fibrosis in a similar case of PHSD (original 
magnification X400 periodic acid-Schiff).
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4.6 Corneal pigmentations
Iron lines: there are multiple theories behind the formation of such lines with 
iron deposits typically within the corneal epithelium at various levels [57].  
They include:
1. Hudson-Stahli line: in aging cornea
2. Stocker’s line: at the edge of chronic pterygium
3. Fleischer’s ring: at the base of the corneal protruding cone in keratoconus
4. Ferry’s line: in front of a filtering bleb
5. Ectatic corneal disorders
5.1 Keratoconus
Dudell in 1729 described a patient with protruding cornea and deteriorating 
vision; this was the earliest references to keratoconus [65]. Initial classifica-
tion of the disease was dependent on the clinical pattern of the ectatic cone and 
included round or nipple cones with a central or oval protrusion and oval cones 
(Figure 17A). Amsler contributed to the disease detection by using a Placido’s 
disk to determine early cases [66]. In the 1980s, the first color-coded Placido map 
of corneal curvature was published and led to multiple commercially available 
computerized video-keratoscopes [67, 68]. Then the more detailed elevation-based 
topographic devices and pachymetric mapping were developed and enabled more 
through assessment of the condition.
The onset of keratoconus typically begins at puberty but might begin during 
childhood and undergoes variable progression until the third or fourth decade 
[69–71]. It is a bilateral condition that is highly asymmetrical that can be associated 
with atopy, Down’s syndrome, Leber’s congenital amaurosis, retinitis pigmentosa, 
Marfan’s syndrome, and mitral valve prolapse [65, 72].
It can present as a sporadic condition; a positive family history has been docu-
mented not infrequently. It is suggested that that there is an autosomal dominant 
form of the disorder with variable phenotypic expression in 90% of those with 
familial keratoconus [65, 73].
The symptoms may vary widely depending on the degree of astigmatism, degree 
of irregularity, and presence of scarring. Slit lamp findings may include the presence 
of a Fleischer’s ring, which is iron epithelial deposits (described earlier), and can be 
Figure 17. 
(A) The clinical thinning of the ectatic cornea in keratoconus (KC) and (B) a Fleischer ring indicating iron 
deposition around the cone in a case of keratoconus.
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Figure 18. 
Topography showing steep keratometry maps with irregular astigmatism mirroring the area of thinning with 
high reading on anterior and posterior elevation maps.
seen better with the use of the cobalt blue filter (Figure 17B) [72]. Reticular scarring 
at the level of bowman’s lay can be seen as well as striations in Descemet’s membrane 
and the deep stroma (Vogt’s striae). These striations represent corneal stress lines 
that parallel the axis of the cone [65, 74]. In advanced cases of keratoconus, Munson’s 
sign and Rizzuti’s sign can also be seen on gross inspection [75]. Ophthalmoscopy can 
show the outline of the early cone as an oil droplet against the background red reflex 
of the fundus. Retinoscopy on a patient with early keratoconus may show scissoring 
of the retinoscopic reflex. In cases of severe keratoconus, individuals might develop 
an acute onset of pain, blurred vision, and photophobia. Examination reveals diffuse 
corneal edema that results from a break in Descemet’s membrane.
The ability to detect early and subclinical (forme fruste) keratoconus might be 
difficult depending on clinical examination alone. The use of corneal topographies 
has improved our ability to distinguish very early cases. Many indices were proposed 
and artificial intelligence methods such as the KISA% index and the Rabinowitz-
McDonnell test have all been developed to help diagnose keratoconus in different 
stages of the disease and most importantly in early cases. Recent efforts looking at 
the relational thickness of the central and peripheral cornea have been helpful in the 
early detection of disease [76]. Modern elevation-based corneal topography provides 
three-dimensional reconstruction of the cornea enabling evaluation of the anterior 
and posterior corneal surfaces and assessing the thickness maps (Figure 18).
Histopathological studies of corneas with keratoconus demonstrated breaks in 
Bowman’s layer or the complete absence of the layer, stromal collagen disorganiza-
tion, scarring, and generalized central thinning of the stroma (Figure 19A).
Treatment options start with spectacle correction, toric soft contact lens, and 
hard contact lens wear. In some cases, the use of intrastromal corneal implants 
might be helpful. Keratoplasty (lamellar or penetrating) is reserved for more 
advanced cases with an overall good success rate (Figure 19B).
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5.2 Pellucid marginal degeneration
Pellucid marginal degeneration (PMD) is an ectatic corneal disease that is 
progressive, bilateral noninflammatory, with thinning involving the inferior cornea 
in a crescentic pattern [65]. Typically, this thinning occurs inferiorly 1–3 mm from 
the limbus (Figure 20A and B). A band of normal cornea is found inferior to the 
ectatic area. This configuration causes the superior cornea to protrude over the ecta-
sia causing a “beer belly” configuration [77]. PMD affecting the superior cornea 
is documented in the literature [78–81]. There might be an association with vernal 
keratoconjunctivitis, atopy, and frequent rubbing of the ocular surface [65].
It can be managed by hard contact lenses or soft toric contact lens. Surgical 
treatment options are technically difficult and have lower success rates than in 
keratoconus. Crescentic lamellar keratoplasty, epikeratoplasty, and corneal wedge/
resection all have been attempted with variable results.
5.3 Keratoglobus
Keratoglobus is a rare, noninflammatory ectatic disorder characterized by 
bilateral corneal from limbus to limbus. The corneal diameter is typically normal, 
and the cornea is clear, except in cases of hydrops. It can be associated with two 
autosomal recessive diseases, Ehlers-Danlos and Blue-Sclera syndrome. Acquired 
keratoglobus may appear de novo or may be associated with other ocular diseases, 
such as vernal keratoconjunctivitis, blepharitis, Leber’s congenital amaurosis, and 
thyroid ophthalmopathy [82].
Figure 19. 
(A) The evident stromal thinning with compensatory thickening of the epithelium and breaks in Bowman’s 
layer in KC (original magnification 100× periodic acid-Schiff) and (B) the postoperative appearance of 
lamellar keratoplasty done for a patient with keratoconus.
Figure 20. 
(A) Slit lamp lit appearance of peripheral corneal thinning in a case of pellucid marginal degeneration 
(PMD) and (B) side view of the inferior corneal bulge in PMD.
Frontiers in Ophthalmology and Ocular Imaging
28
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Penetrating keratoplasty, while the classical surgical treatment for other corneal 
diseases, is not appropriate in keratoglobus patients. Other procedures, such as inlay 
lamellar keratoplasty and limbus-to-limbus epikeratoplasty, have been attempted 
with variable results [83–85]. Preferably a spectacle correction as this also provides 
protection from rupture. Contact lenses can also be used.
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